La SFET
Colloques SFET
Toxicon
E-Books RT
Toxinologie
Fonds documentaires
Ressources humaines

Accueil arrow Colloques SFET arrow Archives RT arrow RT20 (2012) : From Threats to Benefits
RT20 (2012) : From Threats to Benefits Version imprimable Suggérer par mail

"Toxins : From Threats to Benefits"

10 - 11 December 2012, Pasteur Institute, Paris - France

 

 

  • Welcome. Denis SERVENT (SFET President)

  • Marie-France Martin-Eauclaire
    Faculté de Médecine de Marseille, France
    History of the SFET

 

Session 1 - Threats: Exposure and Risks
Chairmen : Dietrich Mebs, Jorge Diogene

 

  • Jorge Diogene
    IRTA, Ctra. Poble Nou, 43540 Sant Carles de la Ràpita, Spain
    Emerging Marine Toxins 
  • Magalie Labadie
    Toxicologie Clinique. Centre antipoison et de toxicovigilance de Bordeaux, France
    Physalia envenimation
  • Mélanie Roué
    IRD, Papeete, France
    Giant Clams: New vectors of ciguatera?
  • Rómulo Aráoz
    Institut Fédératif de Neurobiologie Alfred Fessard, Gif-sur-Yvette, France
    Coupling a Torpedo microplate-receptor binding assay with mass spectrometry to detect freshwater and marine toxins acting on nicotinic acetylcholine receptor
  • Max Goyffon
    MNHN, Paris, France.
    Snakebites by "harmless" snakes: What is a venomous snake? 
  • Andy Pickett
    Toxin Science Limited, Wrexham, UK.
    Risks associated with botulinum toxin in clinical use 
  • Didier Hilaire
    DGA MNRBC, Vert le Petit, France.
    Forensic identification of toxins classified as a threat agent for military or bioterrorist use

  • Poster session - Vote for SFET-CA election

Session 2 - Genesis and Evolution
Chairmen : Juan Calvete, Daniel Ladant

 

  • Michel Simonet
    Institut de Biologie de Lille, France.
    Bacterial toxins and mobile genetic elements 
  • Michel Popoff
    Bactéries anaérobies et Toxines, Institut Pasteur, Paris.
    Evolution of Clostridial Toxins
  • Juan Calvete
    Instituto de Biomedicina de Valencia, Valencia, Spain.
    Towards an integrated omics approach to understand venom evolution
  • Ricardo C. Rodríguez de la Vega
    Laboratoire Ecologie, Systématique et Evolution, Université Paris-Sud, Orsay, France
    Convergence and divergence in animal venoms
  • Guillaume Blanchet
    CEA, iBiTec-S, Service d’Ingénierie Moléculaire des Protéines, Gif-sur-Yvette, France
    An evolutionary approach of mamba venoms: ”le hasard et la nécessité”

 

  • Pasteur Museum Visit - General Assembly of the SFET (SFET members)
  • Gala Dinner  

 

Session 3 - Molecular and Cellular Targets

Chairmen : Michel Popoff, Jordi Molgó

 

  • Holger Barth
    Institute of Pharmacology and Toxicology, University of Ulm Medical Center, Ulm, Germany
    Clostridium botulinum C3 protein: A novel transporter for selective delivery of proteins into the cytosol of monocytes/macrophages
  • Andreas Rummel
    Institut für Toxikologie, Medizinische Hochschule Hannover, Hannover, Germany
    The biological activity of botulinum neurotoxins
  • Cesare Montecucco
    Università degli Studi di Padova, Padova, Italy
    Membrane translocation of tetanus and botulinum neurotoxins
  • Mauricio Montal
    University of California San Diego
    Blocking botulism: A journey into modules and modulators
  • Laetitia Wioland
    Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France
    Clostridium perfringens Epsilon Toxin acts on granule cells and on oligodendrocytes leading to demyelination
  • Alexandre Chenal
    Pasteur Institute, Paris, France
    Calcium-induced folding of intrinsically disordered RTX proteins: Implications for RTX toxin physiology
  • Aurelia Tubaro
    Agriculture and Environmental Sciences Department, University of Udine, Udine, Italy
    Toxicological effects of palytoxin and yessotoxin
  • Angélique Vétillard
    Equipe Venin et activité biologique, Université de Toulouse, France
    Transcriptome analysis of expressed sequence tags (ESTs) from the venom glands of the ant species Tetramorium bicarinatum (Hymenoptera: Formicidae)

 

  • Poster session

 

Session 4 - Benefits: Toxinotherapeutics
Chairmen : Mike Pennington, Sylvie Diochot

 

  • Daniel Gillet
    CEA, iBiTec-S, Service d’Ingénierie Moléculaire des Protéines, Gif sur Yvette, France
    Inhibitor of HB-EGF derived form diphtheria toxin, for the treatment of HB-EGF-related diseases
  • Mike Pennington
    Peptides International, 11621 Electron Drive, Louisville, KY 40299, USA
    Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases
  • Adrijana Leonardi
    Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Ljubljana, Slovenia
    Discovering innovative drugs and diagnostic tools to control haemostasis by venomics of the Vipera a. ammodytes snake

  • Sylvie Diochot
    IPMC, Université Nice-Sophia Antipolis, Valbonne, France
    Black mamba venom peptides target acid-sensing ion channels to abolish pain
  • Grazyna Faure
    Pasteur Institute, Paris, France
    Correcting effect of PLA2 subunit of crotoxin on mutated CFTR: original perspective to investigate the pharmacotherapy of Cystic Fibrosis 
  • Marion Verdoni
    Institut de Chimie Radicalaire, Faculté des Sciences et Techniques, Université Aix-Marseille, France
    For the first time, new inhibitors peptides of melanogenesis isolated from venoms

  • Closure. Denis SERVENT (SFET President)

 


 

Dernière mise à jour : ( 19-07-2013 )
 

contact SFET

Pour toute information sur la SFET

Cet e-mail est protégé contre les robots collecteurs de mails, votre navigateur doit accepter le Javascript pour le voir

 

Fonds documentaires


couv-eventail.gif


Collection SFET
Ouvrages de référence ...
{en savoir + }